Oncodaily company information, Employees & Contact Information

Nikhil Thaker: AI-Powered Internet of Medical Things in Radiation Oncology Oncodaily

Myeloma Paper of the Day, October 28th, Suggested by Robert Orlowski Oncodaily

Norman Ng: An Open Letter Honoring Hong Kong’s Healthcare Workers Oncodaily

6th ESMO in the Alps Oncodaily

SIO and OncoDaily Announce Strategic Partnership to Advance Integrative Oncology Worldwide Oncodaily

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team Oncodaily

Glioblastoma Remission Rate: What Patients Need to Know Oncodaily

ABC Global Alliance and OncoDaily Announce Strategic Partnership to Advance Global Collaboration in Advanced Breast Cancer Oncodaily

10 Posts Not to Miss from ESMO Oncodaily

Alisher Kahharov’s Journey to Becoming an ESO College Graduate Oncodaily

Myeloma Paper of the Day, October 27th, Suggested by Robert Orlowski Oncodaily

Hathal Haddad: Strengthening Global Cooperation to Tackle Prostate Cancer Oncodaily

From Pandemic to Oncology: COVID Vaccine Ups Cancer Response Oncodaily

Eric Van Cutsem Oncodaily

Nazanin Derakhshan: New Course on Psychological Wellbeing for Cancer Survivors Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

ESMO 2025 – The Grand Catch-Up (Berlin, October 17-21, 2025) Oncodaily

Myeloma Paper of the Day, October 24th, Suggested by Robert Orlowski Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

C Ola Landgren: FDA Approved GSK’s Drug, Blenrep Oncodaily

Immunotherapy Success Rate for Breast Cancer. What Patients Need to Know in 2025 Oncodaily

ESMO 2025 Day 3 Highlights Not to Miss Oncodaily

2026 ASCO GU Cancers Symposium Oncodaily

Top Liver and Pancreatic Cancer Trials to Watch at ESMO 2025 Oncodaily

Amalya Sargsyan: Wrapping up ESMO25 with New Connections, People and Science Oncodaily

Texas Lung Cancer Conference 2026 Oncodaily

Elen Baloyan: The Power Behind the Voice of Oncology Oncodaily

ESMO 2025 Day 2 Highlights Not to Miss Oncodaily

Matthew Kurian: ESMO25 – TROP2 ADC Showdown in 1L mTNBC Oncodaily

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy Oncodaily

OncoDaily Party Berlin 2025 Oncodaily

Findings from the Global Cancer Movement – Challenging the Status Quo in Colorectal Cancer Congress published in OncoDaily Medical Journal Oncodaily

Making ESMO25 an Unforgettable Experience Together – ESMO Oncodaily

Highlights From SIOP 2025 Congress: Part 2 Oncodaily

ESMO 2025 Day 5 Highlights Not to Miss Oncodaily

ESMO 2025 Day 4 Highlights Not to Miss Oncodaily

ALASCCA Trial Results: Low-Dose Aspirin in PI3K-Altered CRC Oncodaily

12 Posts Not to Miss From AACRpan25 Oncodaily

Caroline Michie: Reflections on ESMO 2025 Oncodaily

ESMO 2025 Day 1 Highlights Not to Miss Oncodaily

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025 Oncodaily

Artificial Intelligence in Cancer Drug Discovery in 2025 Oncodaily

CompARE Phase III Trial — Standard CRT Remains Benchmark as Durvalumab Sequencing Shows no OS Gain Oncodaily

OncoDaily Grand Rounds: GI Edition during ESMO 2025, Berlin Oncodaily

Ryan Nipp: Excellent Presentation by Ryan Huey at ASCOQLTY25 Oncodaily

Pawel Sobczuk: Attending the ESMO Congress Has Never Been More Exciting Oncodaily

EDGE Gastric Study at ESMO 2025: Domvanalimab + Zimberelimab Plus FOLFOX Shows Durable Survival Oncodaily

Timothée Olivier: Revisiting NATALEE Results Through Sensitivity Analyses Oncodaily

Shushan Hovsepyan: What ESMO Without OncoDaily Party Oncodaily

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

FORTITUDE-101 Trial at ESMO 2025 Presidential: BEMA Plus Chemotherapy in FGFR2b-Positive Gastric Cancer Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

Mapping the World’s Highest and Lowest Cancer Rates Oncodaily

Bárbara Sarni Sanches: Looking Forward to Making Science with OncoDaily Medical Journal Oncodaily

OncoDaily Grand Rounds at ESMO 2025: GI Edition with Dr. Yelena Janjigian and Friends Oncodaily

Mohammed Ibrahim: A Key Step Towards Launching Our Radiotherapy Services Oncodaily

Gevorg Tamamyan: A Story Everyone Must Read Oncodaily

BEGONIA Trial Reports Durable Efficacy of Datopotamab Deruxtecan and Durvalumab in Advanced Triple-Negative Breast Cancer Oncodaily

10-Minute Immunotherapy Infusion: Safe, Efficient Delivery of Nivolumab and Pembrolizumab Oncodaily

ASCO Announces the ASCOQLTY25 Featured Voices Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

Padraic O’Malley: Meet the Experts of VIRO 2025 Oncodaily

Global Voices in Renal Oncology (VIRO) 2025 Oncodaily

KEYNOTE-905 (EV-303) Trial Updates: Pembrolizumab Plus Enfortumab Vedotin Significantly Improves Survival in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer Oncodaily

ASTRO25 Spotlight by Nataliya Kovalchuk Oncodaily

Unreleased Decision Letters From 2024–2025 Now Available – FDA Oncodaily

100 Oncologists, One Community: Reflections from the First ESO College Convention Oncodaily

Immigration and Cancer Outcomes: Bridging the Gap in Healthcare Access Oncodaily

Elizabeth Wulff-Burchfield: Meet the Experts of VIRO 2025 Oncodaily

Post-Trastuzumab Deruxtecan Outcomes in Metastatic Breast Cancer Oncodaily

ESO-OncoDaily Educational Workshop in Breast and GI Oncology Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

RadComp Trial Highlights at ASTRO 2025 Oncodaily

Çağatay Arslan: Meet the Experts of VIRO 2025 Oncodaily

Al-Ola Abdallah’s Highlights from KaSCO 2025 Oncodaily

Joe Biden Diagnosed with Aggressive Metastatic Prostate Cancer at Age 82 Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

Alberto Puccini: Practical Definition of Cure in Patients with Colon Cancer Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

The IMPACT-EU Project has Officially Kicked Off – SIOP Europe Oncodaily

TORPEdO Trial: Proton vs. Photon Therapy in Oropharyngeal Cancer Oncodaily

Top-Paying Oncology Specialties Worldwide in 2025 Oncodaily

Be Where the Latest Breakthroughs Are Being Shared – ESMO Oncodaily

10 Must-Read Posts in GI Oncology This Week Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

100 Influential People in Oncology 2025 – Nominations are Open! Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

Tucatinib (Tukysa): Uses in Cancer, Side Effects, Dosage, Expectations, and More Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

Highlights from Day 2 of VIRO 2025: Charting the Future of Renal Oncology on the Final Day Oncodaily

SIOG and OncoDaily Announce Strategic Partnership to Advance Global Geriatric Oncology Oncodaily

Everything You Need to Know About Immunotherapy at ESMO 2025 Oncodaily

Breast Cancer Cure Rate: A Comprehensive Overview Oncodaily

20 Posts Not to Miss from ASCO 2025 Oncodaily

The Yvonne Awards and OncoDaily Party 2025 Photos Oncodaily

Inside ASCO25 Exhibition – Who did it the best? Oncodaily

10 Must-Read Posts in Immuno-Oncology This Week Oncodaily

Climate Change and Cancer: Protecting Vulnerable Populations Oncodaily